rs1052555

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000400.4(ERCC2):​c.2133C>T​(p.Asp711Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.306 in 1,613,738 control chromosomes in the GnomAD database, including 80,717 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.26 ( 6022 hom., cov: 32)
Exomes 𝑓: 0.31 ( 74695 hom. )

Consequence

ERCC2
NM_000400.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -0.818

Publications

79 publications found
Variant links:
Genes affected
ERCC2 (HGNC:3434): (ERCC excision repair 2, TFIIH core complex helicase subunit) The nucleotide excision repair pathway is a mechanism to repair damage to DNA. The protein encoded by this gene is involved in transcription-coupled nucleotide excision repair and is an integral member of the basal transcription factor BTF2/TFIIH complex. The gene product has ATP-dependent DNA helicase activity and belongs to the RAD3/XPD subfamily of helicases. Defects in this gene can result in three different disorders, the cancer-prone syndrome xeroderma pigmentosum complementation group D, trichothiodystrophy, and Cockayne syndrome. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]
ERCC2 Gene-Disease associations (from GenCC):
  • cerebrooculofacioskeletal syndrome 2
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • trichothiodystrophy 1, photosensitive
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Illumina, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
  • xeroderma pigmentosum group D
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Laboratory for Molecular Medicine, ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • sarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • COFS syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • trichothiodystrophy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • xeroderma pigmentosum
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • xeroderma pigmentosum-Cockayne syndrome complex
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 19-45352266-G-A is Benign according to our data. Variant chr19-45352266-G-A is described in ClinVar as Benign. ClinVar VariationId is 256018.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.818 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.33 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ERCC2NM_000400.4 linkc.2133C>T p.Asp711Asp synonymous_variant Exon 22 of 23 ENST00000391945.10 NP_000391.1 P18074-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ERCC2ENST00000391945.10 linkc.2133C>T p.Asp711Asp synonymous_variant Exon 22 of 23 1 NM_000400.4 ENSP00000375809.4 P18074-1

Frequencies

GnomAD3 genomes
AF:
0.256
AC:
38856
AN:
152004
Hom.:
6024
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.112
Gnomad AMI
AF:
0.418
Gnomad AMR
AF:
0.207
Gnomad ASJ
AF:
0.360
Gnomad EAS
AF:
0.0612
Gnomad SAS
AF:
0.326
Gnomad FIN
AF:
0.396
Gnomad MID
AF:
0.323
Gnomad NFE
AF:
0.334
Gnomad OTH
AF:
0.266
GnomAD2 exomes
AF:
0.282
AC:
70750
AN:
251206
AF XY:
0.295
show subpopulations
Gnomad AFR exome
AF:
0.100
Gnomad AMR exome
AF:
0.153
Gnomad ASJ exome
AF:
0.381
Gnomad EAS exome
AF:
0.0651
Gnomad FIN exome
AF:
0.385
Gnomad NFE exome
AF:
0.338
Gnomad OTH exome
AF:
0.312
GnomAD4 exome
AF:
0.312
AC:
455390
AN:
1461616
Hom.:
74695
Cov.:
47
AF XY:
0.314
AC XY:
228392
AN XY:
727104
show subpopulations
African (AFR)
AF:
0.102
AC:
3406
AN:
33478
American (AMR)
AF:
0.159
AC:
7132
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.374
AC:
9786
AN:
26132
East Asian (EAS)
AF:
0.0433
AC:
1719
AN:
39700
South Asian (SAS)
AF:
0.337
AC:
29057
AN:
86252
European-Finnish (FIN)
AF:
0.390
AC:
20786
AN:
53356
Middle Eastern (MID)
AF:
0.358
AC:
2059
AN:
5756
European-Non Finnish (NFE)
AF:
0.327
AC:
363442
AN:
1111844
Other (OTH)
AF:
0.298
AC:
18003
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
19839
39679
59518
79358
99197
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11436
22872
34308
45744
57180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.255
AC:
38849
AN:
152122
Hom.:
6022
Cov.:
32
AF XY:
0.257
AC XY:
19127
AN XY:
74360
show subpopulations
African (AFR)
AF:
0.111
AC:
4626
AN:
41498
American (AMR)
AF:
0.207
AC:
3162
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.360
AC:
1248
AN:
3468
East Asian (EAS)
AF:
0.0607
AC:
315
AN:
5188
South Asian (SAS)
AF:
0.328
AC:
1577
AN:
4814
European-Finnish (FIN)
AF:
0.396
AC:
4185
AN:
10576
Middle Eastern (MID)
AF:
0.313
AC:
92
AN:
294
European-Non Finnish (NFE)
AF:
0.334
AC:
22711
AN:
67970
Other (OTH)
AF:
0.262
AC:
553
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1403
2807
4210
5614
7017
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
400
800
1200
1600
2000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.303
Hom.:
19989
Bravo
AF:
0.230
Asia WGS
AF:
0.160
AC:
561
AN:
3478
EpiCase
AF:
0.344
EpiControl
AF:
0.344

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency, variant associated with reduced cancer risk -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 01, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 15834925) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Xeroderma pigmentosum, group D Benign:2
Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cerebrooculofacioskeletal syndrome 2 Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Trichothiodystrophy 1, photosensitive Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
0.34
DANN
Benign
0.85
PhyloP100
-0.82
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1052555; hg19: chr19-45855524; COSMIC: COSV67266435; COSMIC: COSV67266435; API